Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Glucose Meter Draft Guidelines Attract More Criticism From Congress

This article was originally published in The Gray Sheet

Executive Summary

FDA draft guidance documents on glucose meters issued in January propose new accuracy standards that stray from updated international norms and would inappropriately restrict the use of OTC meters in health care facilities when needed, 85 lawmakers from the congressional Diabetes Caucus argue in a letter to Commissioner Hamburg.


Related Content

FDA Tempers Accuracy Standards For Hospital Glucose Meters In Final Guidance
FDA Catches Heat For Plans To Raise Standards For Hospital Glucose Meters





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts